Download PDF
Z Gastroenterol 2004; 42(9): 1002-1006
DOI: 10.1055/s-2004-813519
Leitlinien

© Karl Demeter Verlag im Georg Thieme Verlag KG Stuttgart · New York

Ernährung

NutritionS. C. Bischoff1 , W. Fleig2
  • 1Medizinische Hochschule Hannover, Abt. Gastroenterologie, Hepatologie und Endokrinologie, Hannover
  • 2Martin-Luther-Universität Halle-Wittenberg, Klinik und Poliklinik für Innere Medizin I, Halle
Further Information

Publication History

Publication Date:
29 September 2004 (online)

Also available at
    Permissions and Reprints

Präambel

Der Abschnitt „Ernährung” der Leitlinie Colitis ulcerosa” wurde unter Einbeziehung der neueren Literatur aktualisiert. Dabei wurde die 2002 erschienene Leitlinie „Enterale Ernährung” der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) berücksichtigt [1]. Der vorliegende Abschnitt berücksichtigt Besonderheiten bei Kindern, auf die, soweit nötig, in den einzelnen Unterabschnitten gezielt eingegangen wird.

Literatur

  • 1 Luebke H, Meier R, Lochs H. et al . DGEM-Leitlinie Enterale Ernährung: Gastroenterologie.  Akt Ernaehr Med. 2003;  69-86 (IV)
    PubMedGoogle Scholar
  • 2 Soncini M, Triossi O, Leo P. et al . Inflammatory bowel disease and hospital treatment in Italy: the RING multi-centre study.  Aliment Pharmacol Ther. 2004;  19 63-68 (IIb)
    CrossrefPubMedGoogle Scholar
  • 3 Capristo E, Mingrone G, Addolorato G. et al . Metabolic features of inflammatory bowel disease in a remission phase of the disease activity.  J Intern Med. 1998;  243 339-347 (III)
    CrossrefPubMedGoogle Scholar
  • 4 Jones L A, Harries A D, Rhodes J. et al . Normal energy intake in undernourished patients with Crohn’s disease.  Br Med J (Clin Res Ed). 1984;  288 193 (III)
    PubMedGoogle Scholar
  • 5 Brandes J W, Stenner A, Martini G A. Dietary habits of patients with ulcerative colitis.  Z Gastroenterol. 1997;  17 834-842 (III)
    PubMedGoogle Scholar
  • 6 Tragnone A, Valpiani D, Miglio F. et al . Dietary habits as risk factors for inflammatory bowel disease.  Eur J Gastroenterol Hepatol. 1995;  7 47-51 (III)
    PubMedGoogle Scholar
  • 7 Klein S, Meyers S, O’Sullivan P. The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balance.  J Clin Gastroenterol. 1998;  10 34-40 (III)
    PubMedGoogle Scholar
  • 8 Rath H C, Caesar I, Roth M. et al . [Nutritional deficiencies and complications in chronic inflammatory bowel diseases].  Med Klin (Munich). 1998;  93 6-10 (III)
    PubMedGoogle Scholar
  • 9 Franklin J L, Rosenberg H H. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine).  Gastroenterology. 1973;  64 517-525 (IIb)
    PubMedGoogle Scholar
  • 10 Lashner B A. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis.  J Cancer Res Clin Oncol. 1993;  119 549-554 (IIb)
    CrossrefPubMedGoogle Scholar
  • 11 Boot A M, Bouquet J, Krenning E P. et al . Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.  Gut. 1998;  42 188-194 (IIb)
    CrossrefPubMedGoogle Scholar
  • 12 von Tirpitz C, Steder-Neukamm U, Glas K. et al . Osteoporose bei chronisch entzündlichen Darmerkrankungen - Ergebnisse einer Umfrage an Mitgliedern der Deutschen M. Crohn und Colitis ulcerosa Vereinigung (DCCV).  Z Gastroenterol. 2003;  41 1145-1150 (IIb)
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Godine-Zarfl B, Elmadfa I. Body mass index bei 5 - 18jährigen Kindern und Jugendlichen in Österreich.  Ernährungs-Rundschau. 1994;  41 112 (III)
    PubMedGoogle Scholar
  • 14 Ghosh S, Drummond H E, Ferguson A. Neglect of growth and development in the clinical monitoring of children and teenagers with inflammatory bowel disease: review of case records.  Bmj. 1998;  317 120-121 (III)
    PubMedGoogle Scholar
  • 15 Geerling B J, Badart-Smook A, Stockbrugger R W. et al . Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls.  Eur J Clin Nutr. 2000;  54 514-521 (IIa)
    CrossrefPubMedGoogle Scholar
  • 16 Fasth S, Hulten L, Magnusson O. et al . The immediate and long-term effects of postoperative total parenteral nutrition on body composition.  Int J Colorectal Dis. 1987;  2 139-145 (IIb)
    CrossrefPubMedGoogle Scholar
  • 17 Higgens C S, Keighley M R, Allan R N. Impact of preoperative weight loss and body composition changes on postoperative outcome in surgery for inflammatory bowel disease.  Gut. 1984;  25 732-736 (III)
    CrossrefPubMedGoogle Scholar
  • 18 Lindor K D, Fleming C R, Ilstrup D M. Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn’s disease.  Mayo Clin Proc. 1985;  60 393-396 (III)
    CrossrefPubMedGoogle Scholar
  • 19 Fasth S, Hulten L, Magnusson O. et al . Postoperative complications in colorectal surgery in relation to preoperative clinical and nutritional state and postoperative nutritional treatment.  Int J Colorectal Dis. 1987;  2 87-92 (IIa)
    CrossrefPubMedGoogle Scholar
  • 20 Gasche C, Dejaco C, Waldhoer T. et al . Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial.  Ann Intern Med. 1997;  126 782-787 (Ib)
    CrossrefPubMedGoogle Scholar
  • 21 Gasche C, Dejaco C, Reinisch W. et al . Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.  Digestion. 1999;  60 262-267 (III)
    CrossrefPubMedGoogle Scholar
  • 22 Harries A D, Jones L A, Danis V. et al . Controlled trial of supplemented oral nutrition in Crohn’s disease.  Lancet. 1983;  1 887-890 (IIb)
    PubMedGoogle Scholar
  • 23 Schreiber S, Howaldt S, Schnoor M. et al . Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.  N Engl J Med. 1996;  334 619-623 (Ib)
    PubMedGoogle Scholar
  • 24 Lashner B A, Provencher K S, Seidner D L. et al . The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis.  Gastroenterology. 1997;  112 29-32 (Ib)
    CrossrefPubMedGoogle Scholar
  • 25 Dickinson R J, Ashton M G, Axon A T. et al . Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis.  Gastroenterology. 1980;  79 1199-1204 (Ib)
    PubMedGoogle Scholar
  • 26 McIntyre P B, Powell-Tuck J, Wood S R. et al . Controlled trial of bowel rest in the treatment of severe acute colitis.  Gut. 1986;  27 481-485 (Ib)
    PubMedGoogle Scholar
  • 27 Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M. et al . Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis.  Am J Gastroenterol. 1993;  88 227-232 (IIb)
    PubMedGoogle Scholar
  • 28 Stenson W F, Cort D, Rodgers J. et al . Dietary supplementation with fish oil in ulcerative colitis.  Ann Intern Med. 1992;  116 609-614 (Ib)
    PubMedGoogle Scholar
  • 29 Loeschke K, Ueberschaer B, Pietsch A. et al . n-3 fatty acids only delay early relapse of ulcerative colitis in remission.  Dig Dis Sci. 1996;  41 2087-2094 (Ib)
    PubMedGoogle Scholar
  • 30 Kanauchi O, Mitsuyama K, Homma T. et al . Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial.  Int J Mol Med. 2003;  12 701-704 (III)
    PubMedGoogle Scholar
  • 31 Kanauchi O, Suga T, Tochihara M. et al . Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial.  J Gastroenterol. 2002;  37 (Suppl 14) 67-72 (IIa)
    PubMedGoogle Scholar
  • 32 Dichi I, Frenhane P, Dichi J B. et al . Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis.  Nutrition. 2000;  16 87-90 (Ib)
    CrossrefPubMedGoogle Scholar
  • 33 Middleton S J, Naylor S, Woolner J. et al . A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis.  Aliment Pharmacol Ther. 2002;  16 1131-1135 (Ib)
    CrossrefPubMedGoogle Scholar
  • 34 Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana J L. et al . Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn’s Disease and Ulcerative Colitis (GETECCU).  Am J Gastroenterol. 1999;  94 427-433 (Ib)
    PubMedGoogle Scholar
  • 35 Thirlby R C, Kelly R. Pectin and methyl cellulose do not affect intestinal function in patients after ileal pouch-anal anastomosis.  Am J Gastroenterol. 1997;  92 99-102 (IIb)
    PubMedGoogle Scholar
  • 36 Welters C F, Heineman E, Thunnissen F B. et al . Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis.  Dis Colon Rectum. 2002;  45 621-627 (Ib)
    CrossrefPubMedGoogle Scholar

Prof. Dr. S. C. Bischoff

Medizinische Hochschule Hannover, Abt. Gastroenterologie, Hepatologie und Endokrinologie, Carl-Neuberg-Str. 1

30623 Hannover

Phone: ++ 49/5 11/5 32/22 19

Fax: ++ 49/5 11/5 32/48 96

Email: bischoff.stephan@mh-hannover.de